Sankey It
Loading...
Eli Lilly and Company FY2023 income statement | Sankey It
Sankey It · LLY
Eli Lilly and Company FY2023 income statement
USD · fiscal year ended 2023-12-31
FY2025
FY2024
FY2023
FY2022
FY2021
Quarterly
Annual
comfortable
compact
Hide amounts
Export
Fullscreen
Eli Lilly and Company FY2023 income statement
Flow diagram with 10 nodes and 9 flows for Eli Lilly and Company FY2023 income statement. Values: Product US$28.8B, Collaboration and Other Revenue US$5.3B, Revenue US$34.1B, Cost of Revenue US$7.1B, Gross Profit US$27B, Operating Expenses US$16.3B, Operating Income US$10.8B, Other Expense US$4.2B, Tax US$1.3B, Net Income US$5.2B.
Product
US$28.8B
+13% Y/Y
84% of revenue
Collaboration and Other Revenue
US$5.3B
+72% Y/Y
16% of revenue
Revenue
US$34.1B
+20% Y/Y
Cost of Revenue
(US$7.1B)
+7% Y/Y
21% of revenue
Gross Profit
US$27B
+23% Y/Y
79% margin
Operating Expenses
(US$16.3B)
+23% Y/Y
48% of revenue
Operating Income
US$10.8B
+25% Y/Y
32% margin
Other Expense
(US$4.2B)
+129% Y/Y
12% of revenue
Tax
(US$1.3B)
+134% Y/Y
4% of revenue
Net Income
US$5.2B
-16% Y/Y
15% margin
Net / profit
Inputs
Tax / cost
Copy link
Share on X
Open full screen